期刊文献+

干扰素治疗先后发生不同类型甲状腺疾病一例报告并文献复习 被引量:3

Different forms of thyroid dysfunction in the same patient treated with interferon-a: One case report and literature review
原文传递
导出
摘要 甲状腺疾病是干扰素-α治疗的常见不良反应之一,表现为甲状腺毒症、甲状腺功能减退、双相甲状腺炎。但同一患者干扰素治疗先后发生不同类型甲状腺疾病的情况罕见,国内未见报道,国外仅有个案报道。本文报道1例干扰素-a治疗中先后发生亚急性甲状腺炎和Graves病的病例,复习相关文献并总结其临床特点。
作者 程琳 徐明彤 任萌 黄仁伟 吴木潮 张锦 王晓艺 严励 Cheng Lin Xu Mingtong Ren Meng Huang Renwei Wu Muchao Zhang Jin Wang Xiaoyi Yah Li.(Department of Endocrinology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2016年第12期1027-1029,共3页 Chinese Journal of Endocrinology and Metabolism
  • 相关文献

参考文献1

二级参考文献22

  • 1Manns MP,McHutchison JG,Gordon SC,Rustgi VK,Shiffman M,Reindollar R,Goodman ZD,Koury K,Ling M,Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.Lancet 2001; 358:958-965
  • 2Fried MW,Shiffman ML,Reddy KR,Smith C,Marinos G,Goncales FL Jr,Haussinger D,Diago M,Carosi G,Dhumeaux D,Craxi A,Lin A,Hoffman J,Yu J.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.N Engl J Med 2002; 347:975-982
  • 3Consensus conference.Treatment of hepatitis C.Gastroenterol Clin Biol 2002; 26 Spec No 2:B303-B320
  • 4Preziati D,La Rosa L,Covini G,Marcelli R,Rescalli S,Persani L,Del Ninno E,Meroni PL,Colombo M,Beck-Peccoz P.Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.Eur J Endocrinol 1995; 132:587-593
  • 5Benelhadj S,Marcellin P,Castelnau C,Colas-Linhart N,Benhamou JP,Erlinger S,Bok B.Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.Horm Res 1997; 48:209-214
  • 6Carella C,Mazziotti G,Morisco F,Manganella G,Rotondi M,Tuccillo C,Sorvillo F,Caporaso N,Amato G.Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.J Clin Endocrinol Metab 2001; 86:1925-1929
  • 7Dalgard O,Bjoro K,Hellum K,Myrvang B,Bjoro T,Haug E,Bell H.Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha:no association with either interferon dosage or efficacy of therapy.J Intern Med 2002;251:400-406
  • 8Marazuela M,Garcia-Buey L,Gonzalez-Fernandez B,Garcia-Monzon C,Arranz A,Borque MJ,Moreno-Otero R.Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.Clin Endocrinol (Oxf) 1996; 44:635-642
  • 9Mekkakia-Benhabib C,Marcellin P,Colas-Linhart N,Castel-Nau C,Buyck D,Erlinger S,Bok B.[Natural history of dysthyroidism during interferon treatment of chronic hepatitis C] Ann Endocrinol (Paris) 1996; 57:419-427
  • 10Roti E,Minelli R,Giuberti T,Marchelli S,Schianchi C,Gardini E,Salvi M,Fiaccadori F,Ugolotti G,Neri TM,Braverman LE.Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.Am J Med 1996; 101:482-487

共引文献7

同被引文献32

引证文献3

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部